Series A · Medtech & Devices · Geneva, Switzerland · Founded 2019 · 10–15 employees
ARTIRIA Medical develops revolutionary neurovascular access technology featuring the SmartGUIDE, an FDA-cleared guidewire with a micro-articulated seeking head that enables precise real-time navigation through complex cerebral vessels during stroke treatments. Founded in 2019 as an EPFL spin-off, the company has raised over $6 million in Series A2 funding led by 4FOX Ventures and has already treated patients in clinical trials. Their breakthrough technology addresses the critical challenge of navigating dense brain artery networks during minimally invasive stroke procedures, potentially improving outcomes for the 15 million people affected by stroke annually.
No open roles listed right now.